- Home
- TENX vs GRFX Comparison
TENX vs GRFX Comparison
Compare TENX & GRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENX
- GRFX
- Stock Information
- Founded
- TENX 1967
- GRFX 1981
- Country
- TENX United States
- GRFX Hong Kong
- Employees
- TENX N/A
- GRFX N/A
- Industry
- TENX Biotechnology: Pharmaceutical Preparations
- GRFX
- Sector
- TENX Health Care
- GRFX
- Exchange
- TENX Nasdaq
- GRFX Nasdaq
- Market Cap
- TENX 21.6M
- GRFX 18.1M
- IPO Year
- TENX N/A
- GRFX N/A
- Fundamental
- Price
- TENX $5.68
- GRFX $0.96
- Analyst Decision
- TENX Strong Buy
- GRFX Hold
- Analyst Count
- TENX 3
- GRFX 1
- Target Price
- TENX $16.00
- GRFX N/A
- AVG Volume (30 Days)
- TENX 12.6K
- GRFX 24.7K
- Earning Date
- TENX 05-14-2025
- GRFX 01-01-0001
- Dividend Yield
- TENX N/A
- GRFX 0.02%
- EPS Growth
- TENX N/A
- GRFX N/A
- EPS
- TENX N/A
- GRFX N/A
- Revenue
- TENX N/A
- GRFX $24,184,100.00
- Revenue This Year
- TENX N/A
- GRFX N/A
- Revenue Next Year
- TENX N/A
- GRFX N/A
- P/E Ratio
- TENX N/A
- GRFX N/A
- Revenue Growth
- TENX N/A
- GRFX N/A
- 52 Week Low
- TENX $2.77
- GRFX $0.71
- 52 Week High
- TENX $7.89
- GRFX $2.75
- Technical
- Relative Strength Index (RSI)
- TENX 49.30
- GRFX 50.10
- Support Level
- TENX $5.49
- GRFX $0.75
- Resistance Level
- TENX $5.87
- GRFX $1.04
- Average True Range (ATR)
- TENX 0.27
- GRFX 0.11
- MACD
- TENX 0.03
- GRFX 0.00
- Stochastic Oscillator
- TENX 52.04
- GRFX 56.87
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About GRFX Graphex Group Limited each representing 20
Graphex Group Ltd is engaged in the sale of graphene products. It operates in three segments namely, the Graphene Products Segment includes Processing and sale of graphite and graphene-related products; the Landscape Architecture Design Segment includes Providing landscape architecture design; and the catering business focuses on the operation of restaurants. The company derives the majority of its revenue from the sale of graphene products segment.